North Carolina Board-Podiatry Raleigh, NC - 27607

North Carolina Board-Podiatry is categorized under Podiatrists in Raleigh, NC .

North Carolina Board-Podiatry was established in 0, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Podiatrists business, which does work in the B2C market, and is classified as a Podiatrists, under code number 6213910 by the NAICS.

If you are seeking more information, feel free to contact Carolyn Hannah, Executive Officer at the company’s single location by writing to 1500 Sunday Drive # 102, Raleigh, North Carolina NC 27607 or by phoning (919) 787-5181. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: North Carolina Board-Podiatry
Contact Person: Carolyn Hannah, Executive Officer
Address: 1500 Sunday Drive # 102, Raleigh, North Carolina 27607
Phone Number: (919) 787-5181
Website Address: ncbdn.org
Annual Revenue (USD): $100.000 to $499.999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Podiatrists
SIC Code: 8043
NAICS Code: 6213910
Share This Business:

North Carolina Board-Podiatry was started in 0 to provide professional Podiatrists under the SIC code 8043 and NAICS code 6213910. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Carolyn Hannah, Executive Officer for inquiries that concern North Carolina Board-Podiatry by calling the company number (919) 787-5181, as your correspondence is most welcome. Additionally, the physical location of the single location of North Carolina Board-Podiatry can be found at the coordinates 35.799357,-78.730722 as well as the street address 1500 Sunday Drive # 102 in Raleigh, North Carolina 27607.

For its online presence, you may visit North Carolina Board-Podiatry’s website at ncbdn.org and engage with its social media outlets through on Twitter and on Facebook.